Leading with its benchmark facilities serving the  CRAMs industry, we offer a comprehensive array of dedicated services under its contract manufacturing model that are now available for finished dosage forms.

Our Formulations Capability:

• Liquid formulations - Unit 10 Bavla, India - 4450m² of total constructed area
• Soft Gel Capsules - Unit 13 Bavla, India - over 2780m² of total built-in area
• Sterile Injectable Formulations - Carbogen Amcis, Riom, France

Liquid Formulations:

• A dedicated manufacturing facility of hygiene care formulation products and hospital-grade disinfectants
• Reliable supply as in-house APIs manufacturing
• Different packing type, colour, or fragrance according to customer's requirement
• WHO-GMP certification
• ISO 13485 for Medical Devices complied

Soft Gel Capsules:

Dishman Carbogen Amcis Ltd has largely indulged in developing sophisticated infrastructure, enabling the production of various novel dosage formulations in soft gelatin capsules, such as Therapeutic, Nutraceutical, and OTC.

• pilot Softgel facility - 500m² with 30 million capsules per annum capacity
• commercial softgel facility - 2320m² with 300 million capsules per annum capacity
• The plant is designed to meet the highest regulatory quality standards, including EU, USFDA, WHO GMP

Sterile Injectable Formulations:

With a primary focus on the formulation of complex, potent, and challenging drug products from preclinical to clinical batches in both liquid or freeze-dried form, our facility in Riom has been part of the Dishman Carbogen Amcis Ltd Group since early 2012 and is inspected by the French Health Authority (ANSM) and has ISO 22716 Cosmetics GMP Standard Accreditation.